年間110万人以上の患者に信頼される医療機関。 膝関節または股関節の変形性関節症に対する幹細胞治療

• 免疫検査
• 幹細胞療法
• 術前検査
• 薬剤
• 経過観察
• 消耗品

• 14 日 ホテルで

• 移送は含まれていません

If you suffer from knee or hip osteoarthritis and would like to explore a regenerative treatment before considering joint replacement, I recommend an assessment with Dr. Robert Soler Rich at the Tissue Regenerative Therapy Institute (ITRT), Centro Médico Teknon in Barcelona.

This is not a conventional injection. ITRT uses cultured mesenchymal cells (CMC) developed as an advanced therapy medicinal product under pharmaceutical manufacturing standards. Treatment is considered only after reviewing the degree of osteoarthritis, MRI findings, symptoms and previous conservative treatments. Not every patient is a suitable candidate.

Why Dr. Robert Soler

• Co-founder and Medical Director of ITRT at Centro Médico Teknon.
• More than 30 years of clinical and research experience.
• Has led clinical research programs involving osteoarthritis, tendon injuries, osteonecrosis and other musculoskeletal conditions.
• His work focuses on regulated advanced cell therapies using cultured mesenchymal cells manufactured under GMP conditions.
• ITRT has more than 20 years of clinical research experience with these therapies.

Why Centro Médico Teknon

ITRT operates within Centro Médico Teknon in Barcelona and evaluates advanced cell therapy for osteoarthritis of the knee, hip, shoulder and other peripheral joints.

The treatment is performed within a regulated framework. Cultured cells are prepared under GMP manufacturing conditions, undergo quality and sterility controls, and each application requires individual authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS).

Treatment package

• Specialist consultation with Dr. Robert Soler: approximately €350.
• Review of MRI, X-rays and previous orthopedic treatments.
• Assessment of osteoarthritis grade and suitability for cell therapy.
• Bone marrow collection when an autologous-cell protocol is selected.
• Isolation and cultivation of mesenchymal cells under GMP conditions.
• Cellular characterization and quality-control testing.
• Individual AEMPS authorization process.
• Image-guided intra-articular administration into the knee or hip.
• Medical monitoring after treatment.
• Long-term clinical and imaging follow-up protocol.


A recent 3-Tesla MRI may be required before treatment and is charged separately if adequate imaging is not already available.

Prices are estimates and may change significantly after medical evaluation and the individual cellular protocol.

Who may benefit

The program can be considered for selected patients with symptomatic knee or hip osteoarthritis who continue to experience pain and functional limitation despite conservative treatment.

For knee osteoarthritis, ITRT notes that patients with grade II–III disease generally have a more favorable profile for assessment. Advanced grade IV osteoarthritis, major deformity or severe mechanical joint damage requires particularly careful selection and may still be better treated with joint replacement.

• 専任医療コーディネーター
• 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
• 医療旅行中の患者擁護